INHIBITORY EFFECTS OF SUBSTRATE-BASED BCR-ABL1 KINASE INHIBITORS ON THE GROWTH OF CHRONIC MYELOID LEUKEMIA CELL LINE K562

被引：0

作者：

Huang, Y. -H. ^{[1
]}

Henriques, S. Troeira ^{[1
]}

Lawrence, N. ^{[1
]}

Kaas, Q. ^{[1
]}

Craik, D. J. ^{[1
]}

机构：

[1] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia

来源：

JOURNAL OF PEPTIDE SCIENCE | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

PP IX-257

引用

页码：S174 / S174

页数：1

共 50 条

[41] ND-09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR-ABL signaling (vol 46, 136, 2021) [J].

Liu, Yan-Hong ;

Zhu, Man ;

Lei, Pan-Pan ;

Pan, Xiao-Yan ;

Ma, Wei-Na .

ONCOLOGY REPORTS, 2023, 49 (05)

[42] MOLECULAR RESPONSE TO THERAPY WITH TYROSINE KINASE INHIBITORS IN PATIENTS WITH BCR-ABL1(+) CHRONIC MYELOID LEUKEMIA PRESENTING WITH AN ISOLATED THROMBOCYTOSIS AT THE ONSET [J].

Balatzenko, G. ;

Hrischev, V. ;

Ignatova, K. ;

Stoyanova, Z. ;

Lilova, A. ;

Angelova, S. ;

Ivanova, S. ;

Romanova, M. ;

Ivanova, I. ;

Tsvetkova, G. ;

Hadjiev, E. ;

Madzharova, V. ;

Dikov, T. ;

Spassov, B. ;

Davidkova, Y. ;

Jagurinoski, M. ;

Guenova, M. .

HAEMATOLOGICA, 2017, 102 :733-733

[43] GENETIC MUTATIONS OUTSIDE BCR-ABL1 DETERMINING TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKEMIA [J].

Aref, Salah ;

Abdalla, Nada ;

Muller, Martin ;

El Sharaway, Solofa ;

Aziz, Sherin Abdel ;

Sauselle, Sussane .

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 :17-17

[44] Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells [J].

Tsubaki, Masanobu ;

Takeda, Tomoya ;

Kino, Toshiki ;

Sakai, Kazuko ;

Itoh, Tatsuki ;

Imano, Motohiro ;

Nakayama, Takashi ;

Nishio, Kazuto ;

Satou, Takao ;

Nishida, Shozo .

ONCOTARGET, 2017, 8 (24) :38717-38730

[45] BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia [J].

Amarante-Mendes, Gustavo P. ;

Rana, Aamir ;

Datoguia, Tarcila Santos ;

Hamerschlak, Nelson ;

Brumatti, Gabriela .

PHARMACEUTICS, 2022, 14 (01)

[46] Biological effects of whole Z. Officinale extract on chronic myeloid leukemia cell line K562 [J].

Tiber, Pinar Mega ;

Sevinc, Sevgi Kocyigit ;

Kilinc, Olca ;

Orun, Oya .

GENE, 2019, 692 :217-222

[47] Characterization of interactions of Nck with Cbl Bcr/Abl and other phosphotyrosine proteins in human leukemia cell line K562 [J].

Buday, L ;

Wunderlich, L ;

Gohér, A ;

Faragó, A .

FASEB JOURNAL, 1997, 11 (09) :A919-A919

[48] The K562 chronic myeloid leukemia cell line undergoes apoptosis in response to interferon-α [J].

Luchetti, F ;

Gregorini, A ;

Papa, S ;

Burattini, S ;

Canonico, B ;

Valentini, M ;

Falcieri, E .

HAEMATOLOGICA, 1998, 83 (11) :974-980

[49] THE CHRONIC MYELOCYTIC CELL-LINE K562 CONTAINS A BREAKPOINT IN BCR AND PRODUCES A CHIMERIC BCR/C-ABL TRANSCRIPT [J].

GROSVELD, G ;

VERWOERD, T ;

VANAGTHOVEN, T ;

DEKLEIN, A ;

RAMACHANDRAN, KL ;

HEISTERKAMP, N ;

STAM, K ;

GROFFEN, J .

MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (02) :607-616

[50] Therapeutic effects of tyrosine kinase inhibitors and subtypes of BCR-ABL1 transcripts in Japanese chronic myeloid leukemia patients with three-way chromosomal translocations [J].

Inokuchi, Koiti ;

Nakayama, Kazutaka ;

Tauchi, Tetsuzo ;

Takaku, Tomoiku ;

Yokose, Norio ;

Yamaguchi, Hiroki ;

Kumagai, Takashi ;

Komatsu, Norio ;

Ohyashiki, Kazuma .

LEUKEMIA RESEARCH, 2018, 65 :74-79

← 1 2 3 4 5 →